|
rno05221 |
Acute myeloid leukemia |
4 |
4 |
|
rno04520 |
Adherens junction |
2 |
2 |
|
rno04920 |
Adipocytokine signaling pathway |
4 |
1 |
|
rno04261 |
Adrenergic signaling in cardiomyocytes |
4 |
4 |
|
rno05143 |
African trypanosomiasis |
1 |
1 |
|
rno04933 |
AGE RAGE signaling pathway in diabetic complications |
1 |
1 |
|
rno05034 |
Alcoholism |
2 |
2 |
|
rno04960 |
Aldosterone regulated sodium reabsorption |
6 |
3 |
|
rno04925 |
Aldosterone synthesis and secretion |
2 |
2 |
|
rno05010 |
Alzheimer disease |
10 |
6 |
|
rno05031 |
Amphetamine addiction |
3 |
3 |
|
rno04152 |
AMPK signaling pathway |
7 |
4 |
|
rno05014 |
Amyotrophic lateral sclerosis |
3 |
3 |
|
rno04612 |
Antigen processing and presentation |
1 |
1 |
|
rno04371 |
Apelin signaling pathway |
4 |
4 |
|
rno04210 |
Apoptosis |
2 |
2 |
|
rno05310 |
Asthma |
1 |
1 |
|
rno04140 |
Autophagy animal |
7 |
4 |
|
rno04360 |
Axon guidance |
4 |
4 |
|
rno05100 |
Bacterial invasion of epithelial cells |
6 |
5 |
|
rno05217 |
Basal cell carcinoma |
1 |
1 |
|
rno04662 |
B cell receptor signaling pathway |
2 |
2 |
|
rno04976 |
Bile secretion |
2 |
2 |
|
rno05219 |
Bladder cancer |
2 |
2 |
|
rno05224 |
Breast cancer |
3 |
3 |
|
rno04020 |
Calcium signaling pathway |
5 |
4 |
|
rno04024 |
cAMP signaling pathway |
8 |
8 |
|
rno04973 |
Carbohydrate digestion and absorption |
1 |
1 |
|
rno04260 |
Cardiac muscle contraction |
1 |
1 |
|
rno04514 |
Cell adhesion molecules |
1 |
1 |
|
rno04218 |
Cellular senescence |
2 |
2 |
|
rno05230 |
Central carbon metabolism in cancer |
1 |
1 |
|
rno04022 |
cGMP PKG signaling pathway |
8 |
5 |
|
rno05142 |
Chagas disease |
1 |
1 |
|
rno05208 |
Chemical carcinogenesis reactive oxygen species |
3 |
3 |
|
rno05207 |
Chemical carcinogenesis receptor activation |
6 |
6 |
|
rno04062 |
Chemokine signaling pathway |
9 |
8 |
|
rno04979 |
Cholesterol metabolism |
1 |
1 |
|
rno05231 |
Choline metabolism in cancer |
3 |
3 |
|
rno04725 |
Cholinergic synapse |
3 |
3 |
|
rno05220 |
Chronic myeloid leukemia |
2 |
2 |
|
rno04713 |
Circadian entrainment |
3 |
3 |
|
rno05030 |
Cocaine addiction |
2 |
2 |
|
rno05210 |
Colorectal cancer |
5 |
5 |
|
rno04927 |
Cortisol synthesis and secretion |
1 |
1 |
|
rno04625 |
C type lectin receptor signaling pathway |
2 |
2 |
|
rno04934 |
Cushing syndrome |
3 |
3 |
|
rno05415 |
Diabetic cardiomyopathy |
4 |
1 |
|
rno05414 |
Dilated cardiomyopathy |
1 |
1 |
|
rno04728 |
Dopaminergic synapse |
4 |
4 |
|
rno04512 |
ECM receptor interaction |
1 |
1 |
|
rno01521 |
EGFR tyrosine kinase inhibitor resistance |
6 |
6 |
|
rno04961 |
Endocrine and other factor regulated calcium reabsorption |
3 |
3 |
|
rno01522 |
Endocrine resistance |
5 |
5 |
|
rno04144 |
Endocytosis |
14 |
10 |
|
rno05213 |
Endometrial cancer |
3 |
3 |
|
rno05169 |
Epstein Barr virus infection |
2 |
2 |
|
rno04012 |
ErbB signaling pathway |
7 |
7 |
|
rno04915 |
Estrogen signaling pathway |
5 |
5 |
|
rno04664 |
Fc epsilon RI signaling pathway |
3 |
3 |
|
rno04666 |
Fc gamma R mediated phagocytosis |
7 |
6 |
|
rno05418 |
Fluid shear stress and atherosclerosis |
1 |
1 |
|
rno04510 |
Focal adhesion |
8 |
7 |
|
rno04068 |
FoxO signaling pathway |
6 |
3 |
|
rno04727 |
GABAergic synapse |
3 |
3 |
|
rno04540 |
Gap junction |
6 |
5 |
|
rno04971 |
Gastric acid secretion |
3 |
3 |
|
rno05226 |
Gastric cancer |
3 |
3 |
|
rno05214 |
Glioma |
1 |
1 |
|
rno04724 |
Glutamatergic synapse |
12 |
10 |
|
rno04929 |
GnRH secretion |
2 |
2 |
|
rno04912 |
GnRH signaling pathway |
4 |
4 |
|
rno04935 |
Growth hormone synthesis, secretion and action |
9 |
5 |
|
rno04340 |
Hedgehog signaling pathway |
1 |
1 |
|
rno04640 |
Hematopoietic cell lineage |
1 |
1 |
|
rno05161 |
Hepatitis B |
3 |
3 |
|
rno05160 |
Hepatitis C |
2 |
2 |
|
rno05225 |
Hepatocellular carcinoma |
4 |
4 |
|
rno05168 |
Herpes simplex virus 1 infection |
4 |
4 |
|
rno04066 |
HIF 1 signaling pathway |
3 |
3 |
|
rno04390 |
Hippo signaling pathway |
1 |
1 |
|
rno04392 |
Hippo signaling pathway multiple species |
1 |
1 |
|
rno05163 |
Human cytomegalovirus infection |
7 |
6 |
|
rno05170 |
Human immunodeficiency virus 1 infection |
5 |
5 |
|
rno05165 |
Human papillomavirus infection |
7 |
7 |
|
rno05166 |
Human T cell leukemia virus 1 infection |
3 |
3 |
|
rno05016 |
Huntington disease |
4 |
3 |
|
rno04750 |
Inflammatory mediator regulation of TRP channels |
2 |
2 |
|
rno05164 |
Influenza A |
1 |
1 |
|
rno00562 |
Inositol phosphate metabolism |
2 |
2 |
|
rno04931 |
Insulin resistance |
6 |
3 |
|
rno04911 |
Insulin secretion |
2 |
2 |
|
rno04910 |
Insulin signaling pathway |
8 |
5 |
|
rno05167 |
Kaposi sarcoma associated herpesvirus infection |
3 |
3 |
|
rno05134 |
Legionellosis |
1 |
1 |
|
rno04670 |
Leukocyte transendothelial migration |
3 |
2 |
|
rno05417 |
Lipid and atherosclerosis |
5 |
5 |
|
rno04211 |
Longevity regulating pathway |
7 |
4 |
|
rno04213 |
Longevity regulating pathway multiple species |
7 |
4 |
|
rno04730 |
Long term depression |
5 |
5 |
|
rno04720 |
Long term potentiation |
8 |
7 |
|
rno04010 |
MAPK signaling pathway |
5 |
5 |
|
rno05162 |
Measles |
3 |
3 |
|
rno04916 |
Melanogenesis |
2 |
2 |
|
rno05218 |
Melanoma |
2 |
2 |
|
rno01100 |
Metabolic pathways |
4 |
4 |
|
rno05206 |
MicroRNAs in cancer |
6 |
3 |
|
rno04978 |
Mineral absorption |
1 |
1 |
|
rno04137 |
Mitophagy animal |
1 |
1 |
|
rno05032 |
Morphine addiction |
1 |
1 |
|
rno04150 |
mTOR signaling pathway |
7 |
4 |
|
rno04650 |
Natural killer cell mediated cytotoxicity |
2 |
2 |
|
rno04217 |
Necroptosis |
1 |
1 |
|
rno04080 |
Neuroactive ligand receptor interaction |
8 |
7 |
|
rno04722 |
Neurotrophin signaling pathway |
7 |
4 |
|
rno04613 |
Neutrophil extracellular trap formation |
2 |
2 |
|
rno04064 |
NF kappa B signaling pathway |
3 |
2 |
|
rno05033 |
Nicotine addiction |
4 |
4 |
|
rno04621 |
NOD like receptor signaling pathway |
1 |
1 |
|
rno04932 |
Non alcoholic fatty liver disease |
6 |
3 |
|
rno05223 |
Non small cell lung cancer |
2 |
2 |
|
rno04330 |
Notch signaling pathway |
1 |
1 |
|
rno04114 |
Oocyte meiosis |
2 |
2 |
|
rno04380 |
Osteoclast differentiation |
1 |
1 |
|
rno04913 |
Ovarian steroidogenesis |
1 |
1 |
|
rno04921 |
Oxytocin signaling pathway |
4 |
4 |
|
rno05212 |
Pancreatic cancer |
4 |
4 |
|
rno04972 |
Pancreatic secretion |
2 |
2 |
|
rno04928 |
Parathyroid hormone synthesis, secretion and action |
2 |
2 |
|
rno05012 |
Parkinson disease |
1 |
1 |
|
rno05200 |
Pathways in cancer |
7 |
7 |
|
rno05022 |
Pathways of neurodegeneration multiple diseases |
9 |
8 |
|
rno05235 |
PD L1 expression and PD 1 checkpoint pathway in cancer |
3 |
3 |
|
rno04070 |
Phosphatidylinositol signaling system |
2 |
2 |
|
rno04072 |
Phospholipase D signaling pathway |
8 |
7 |
|
rno04151 |
PI3K Akt signaling pathway |
10 |
7 |
|
rno04611 |
Platelet activation |
3 |
3 |
|
rno01524 |
Platinum drug resistance |
1 |
1 |
|
rno05340 |
Primary immunodeficiency |
1 |
1 |
|
rno05020 |
Prion disease |
2 |
2 |
|
rno04914 |
Progesterone mediated oocyte maturation |
2 |
2 |
|
rno04917 |
Prolactin signaling pathway |
2 |
2 |
|
rno05215 |
Prostate cancer |
2 |
2 |
|
rno04974 |
Protein digestion and absorption |
1 |
1 |
|
rno04141 |
Protein processing in endoplasmic reticulum |
1 |
1 |
|
rno05205 |
Proteoglycans in cancer |
7 |
7 |
|
rno04964 |
Proximal tubule bicarbonate reclamation |
1 |
1 |
|
rno00230 |
Purine metabolism |
1 |
1 |
|
rno04015 |
Rap1 signaling pathway |
6 |
5 |
|
rno04014 |
Ras signaling pathway |
4 |
4 |
|
rno04810 |
Regulation of actin cytoskeleton |
7 |
6 |
|
rno04923 |
Regulation of lipolysis in adipocytes |
5 |
2 |
|
rno04926 |
Relaxin signaling pathway |
3 |
3 |
|
rno05211 |
Renal cell carcinoma |
4 |
4 |
|
rno04614 |
Renin angiotensin system |
1 |
1 |
|
rno04723 |
Retrograde endocannabinoid signaling |
9 |
8 |
|
rno04970 |
Salivary secretion |
2 |
2 |
|
rno05132 |
Salmonella infection |
3 |
3 |
|
rno04726 |
Serotonergic synapse |
3 |
3 |
|
rno04550 |
Signaling pathways regulating pluripotency of stem cells |
2 |
2 |
|
rno00600 |
Sphingolipid metabolism |
1 |
1 |
|
rno04071 |
Sphingolipid signaling pathway |
3 |
3 |
|
rno05017 |
Spinocerebellar ataxia |
3 |
3 |
|
rno03040 |
Spliceosome |
1 |
1 |
|
rno04721 |
Synaptic vesicle cycle |
7 |
7 |
|
rno04742 |
Taste transduction |
4 |
4 |
|
rno04660 |
T cell receptor signaling pathway |
4 |
4 |
|
rno04350 |
TGF beta signaling pathway |
1 |
1 |
|
rno04659 |
Th17 cell differentiation |
1 |
1 |
|
rno04658 |
Th1 and Th2 cell differentiation |
1 |
1 |
|
rno04714 |
Thermogenesis |
2 |
2 |
|
rno05216 |
Thyroid cancer |
1 |
1 |
|
rno04919 |
Thyroid hormone signaling pathway |
4 |
4 |
|
rno04918 |
Thyroid hormone synthesis |
3 |
3 |
|
rno04530 |
Tight junction |
2 |
2 |
|
rno04668 |
TNF signaling pathway |
2 |
2 |
|
rno04620 |
Toll like receptor signaling pathway |
2 |
2 |
|
rno05145 |
Toxoplasmosis |
2 |
2 |
|
rno05152 |
Tuberculosis |
2 |
2 |
|
rno04930 |
Type II diabetes mellitus |
4 |
1 |
|
rno04270 |
Vascular smooth muscle contraction |
2 |
2 |
|
rno04370 |
VEGF signaling pathway |
4 |
4 |
|
rno05203 |
Viral carcinogenesis |
4 |
4 |
|
rno04310 |
Wnt signaling pathway |
1 |
1 |
|
rno05135 |
Yersinia infection |
7 |
6 |